MOSCOW, Sept 18 (Reuters) - Russia's R-Pharm on Friday announced the approval of coronavir for outpatient treatment of mild to moderate COVID-19 coronavirus infection, it said in a statement.
Coronavir, manufactured at R-Pharm's facility in Yaroslavl, will be available in pharmacies, the company added without elaborating.
(Writing by Katya Golubkova Editing by David Goodman )
((email@example.com; +7 495 775 1242;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.